These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38283929)

  • 41. Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations.
    Ciffone N; McNeal CJ; McGowan MP; Ferdinand KC
    Am Heart J Plus; 2024 Feb; 38():100350. PubMed ID: 38510747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein(a) in atherosclerotic cardiovascular disease and proprotein convertase subtilisin/kexin-type 9 inhibitors.
    Lian PA; Zhu WQ; Zhao WX; Huang PP; Ran JL; Tang YX; Huang XS; Li R
    Clin Chim Acta; 2024 Oct; 565():119982. PubMed ID: 39366516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consensus and guidelines on lipoprotein(a) - seeing the forest through the trees.
    Kronenberg F; Mora S; Stroes ESG
    Curr Opin Lipidol; 2022 Dec; 33(6):342-352. PubMed ID: 36251423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.
    Stürzebecher PE; Schorr JJ; Klebs SHG; Laufs U
    Atherosclerosis; 2023 Feb; 367():24-33. PubMed ID: 36764050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
    Tsioulos G; Kounatidis D; Vallianou NG; Poulaki A; Kotsi E; Christodoulatos GS; Tsilingiris D; Karampela I; Skourtis A; Dalamaga M
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoprotein(a) and mortality-a high risk relationship.
    Klingel R; Heibges A; Fassbender C
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):13-19. PubMed ID: 30838554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?
    Catapano AL; Daccord M; Damato E; Humphries SE; Neely RDG; Nordestgaard BG; Pistollato M; Steinhagen-Thiessen E
    Atherosclerosis; 2022 May; 349():136-143. PubMed ID: 35292153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a new apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a).
    Dembinski T; Nixon P; Shen G; Mymin D; Choy PC
    Mol Cell Biochem; 2000 Apr; 207(1-2):149-55. PubMed ID: 10888241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
    Makris A; Barkas F; Sfikakis PP; Liberopoulos E; Filippatos TD; Ray KK; Agouridis AP
    Atheroscler Plus; 2023 Dec; 54():1-6. PubMed ID: 37720252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein (a): Recent Updates on a Unique Lipoprotein.
    Saeed A; Kinoush S; Virani SS
    Curr Atheroscler Rep; 2021 Jun; 23(8):41. PubMed ID: 34146181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions.
    de Boer LM; Wiegman A; Swerdlow DI; Kastelein JJP; Hutten BA
    Expert Opin Pharmacother; 2022 Oct; 23(14):1601-1615. PubMed ID: 36047306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.
    Zhang W; Speiser JL; Ye F; Tsai MY; Cainzos-Achirica M; Nasir K; Herrington DM; Shapiro MD
    J Am Coll Cardiol; 2021 Sep; 78(11):1083-1094. PubMed ID: 34503676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.
    Jawi MM; Frohlich J; Chan SY
    J Lipids; 2020; 2020():3491764. PubMed ID: 32099678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.
    Mehta A; Vasquez N; Ayers CR; Patel J; Hooda A; Khera A; Blumenthal RS; Shapiro MD; Rodriguez CJ; Tsai MY; Sperling LS; Virani SS; Blaha MJ; Joshi PH
    J Am Coll Cardiol; 2022 Mar; 79(8):757-768. PubMed ID: 35210030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease.
    Akyol O; Yang CY; Woodside DG; Chiang HH; Chen CH; Gotto AM
    Curr Atheroscler Rep; 2024 Jul; 26(7):317-329. PubMed ID: 38753254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies.
    Bhatia HS; Wilkinson MJ
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.
    Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Hohenstein B; Roeseler E; Heigl F; Grützmacher P; Blume H; Klingel R; Vogt A;
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):33-38. PubMed ID: 30838552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipoprotein(a) and cardiovascular disease.
    Boffa MB; Koschinsky ML
    Biochem J; 2024 Oct; 481(19):1277-1296. PubMed ID: 39302109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Association of Lipoprotein(a) and Neutrophil-to-Lymphocyte Ratio Combination with Atherosclerotic Cardiovascular Disease in Chinese Patients.
    Wang X; Chen X; Wang Y; Peng S; Pi J; Yue J; Meng Q; Liu J; Zheng L; Chan P; Tomlinson B; Liu Z; Zhang Y
    Int J Gen Med; 2023; 16():2805-2817. PubMed ID: 37426518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.